• HLB Chessboard

Medical Ethics achieves increased investment from Dechra Pharmaceuticals

Updated: Feb 11

The UK based Dechra Pharmaceuticals has announced their increased investment in Medical Ethics. Dechra has investments $13.5 million for a further 15% stake in the company. increasing its holding to 48%.

The full announcement by Dechra Pharmaceuticals can be accessed here.


​© Copyright 2015 HLB Chessboard Pty Ltd. All rights reserved. No portion of this website may be reproduced, copied, or in any way reused without written permission from HLB Chessboard Pty Ltd.

Liability limited by a scheme approved under Professional Standards Legislation.

ABN 41 164 223 394

AFSL 474103